Rankings
▼
Calendar
CAMP Q3 2024 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$125M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$14M
Net Income
-$13M
EPS (Diluted)
$-0.69
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$21M
Total Liabilities
$180M
Stockholders' Equity
-$159M
Cash & Equivalents
$3M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$350,000
-100.0%
Gross Profit
$0
$350,000
-100.0%
Operating Income
-$14M
-$12M
-9.5%
Net Income
-$13M
-$12M
-15.3%
← FY 2024
All Quarters
Q4 2024 →